A phase 2 trial in pancreatic cancer, run by Yonsei University, now recruiting.
Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer is a phase 2, interventional study registered as NCT07257523 by Yonsei University, with a registry enrolment figure of 33 participants, started 2025-09-23 and due to reach its primary completion in 2027-07. Interventions recorded: Carbon Ion Radiotherapy. Conditions listed: Pancreatic Neoplasm. Primary outcome: Overall survival in frail patients with pancreatic cancer receiving carbon ion radiotherapy. Pancreatic eligibility wording from the registry: "\- Histologically confirmed pancreatic cancer without distant metastasis". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.